Matthias Mehling

1 Patent

• US124733542025

  GDF-15 as a Diagnostic Marker to Predict the Clinical Outcome of a Treatment with Immune Checkpoint Blockers

  JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG

  0 cites